Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix.

Huo D, Anderson D, Herbst AL.

N Engl J Med. 2018 May 3;378(18):1746-1748. doi: 10.1056/NEJMc1800097. No abstract available.

2.

Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.

Huo D, Anderson D, Palmer JR, Herbst AL.

Gynecol Oncol. 2017 Sep;146(3):566-571. doi: 10.1016/j.ygyno.2017.06.028. Epub 2017 Jul 6.

PMID:
28689666
3.

Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.

Troisi R, Hatch EE, Palmer JR, Titus L, Robboy SJ, Strohsnitter WC, Herbst AL, Adam E, Hyer M, Hoover RN.

Am J Obstet Gynecol. 2016 Sep;215(3):322.e1-8. doi: 10.1016/j.ajog.2016.03.007. Epub 2016 Mar 12.

4.

Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences.

Herbst AL, Anderson D.

AMA J Ethics. 2015 Sep 1;17(9):865-70. doi: 10.1001/journalofethics.2015.17.9.mhst1-1509. No abstract available.

5.

Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.

Camp EA, Prehn AW, Shen J, Herbst AL, Strohsnitter WC, Hobday CD, Robboy SJ, Adam E.

J Womens Health (Larchmt). 2015 Apr;24(4):308-15. doi: 10.1089/jwh.2014.4930. Epub 2015 Mar 13.

6.

Medical conditions among adult offspring prenatally exposed to diethylstilbestrol.

Troisi R, Hyer M, Hatch EE, Titus-Ernstoff L, Palmer JR, Strohsnitter WC, Herbst AL, Adam E, Hoover RN.

Epidemiology. 2013 May;24(3):430-8. doi: 10.1097/EDE.0b013e318289bdf7.

PMID:
23474687
7.

Mammography screening behaviors of women exposed prenatally to diethylstilbestrol.

Camp EA, Robboy SJ, Hatch EE, Titus-Ernstoff LT, Herbst AL, Strohsnitter W, Kaufman RH, Adam E.

J Womens Health (Larchmt). 2012 Feb;21(2):209-14. doi: 10.1089/jwh.2011.2741. Epub 2011 Dec 8.

PMID:
22150213
8.

Adverse health outcomes in women exposed in utero to diethylstilbestrol.

Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL, Karlan BY, Kaufman R, Noller KL, Palmer JR, Robboy SJ, Saal RC, Strohsnitter W, Titus-Ernstoff L, Troisi R.

N Engl J Med. 2011 Oct 6;365(14):1304-14. doi: 10.1056/NEJMoa1013961.

9.

Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study.

Palmer JR, Herbst AL, Noller KL, Boggs DA, Troisi R, Titus-Ernstoff L, Hatch EE, Wise LA, Strohsnitter WC, Hoover RN.

Environ Health. 2009 Aug 18;8:37. doi: 10.1186/1476-069X-8-37.

10.

Breast cancer screening in women exposed in utero to diethylstilbestrol.

Camp EA, Coker AL, Robboy SJ, Noller KL, Goodman KJ, Titus-Ernstoff LT, Hatch EE, Herbst AL, Troisi R, Kaufman RH, Adam E.

J Womens Health (Larchmt). 2009 Apr;18(4):547-52. doi: 10.1089/jwh.2007.0580.

11.

Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol.

Camp EA, Coker AL, Troisi R, Robboy SJ, Noller KL, Goodman KJ, Titus-Ernstoff LT, Hatch EE, Herbst AL, Kaufman RH, Adam E.

J Low Genit Tract Dis. 2008 Apr;12(2):111-7. doi: 10.1097/LGT.0b013e31815ae980.

PMID:
18369304
12.

Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation.

Titus-Ernstoff L, Troisi R, Hatch EE, Hyer M, Wise LA, Palmer JR, Kaufman R, Adam E, Noller K, Herbst AL, Strohsnitter W, Cole BF, Hartge P, Hoover RN.

Epidemiology. 2008 Mar;19(2):251-7. doi: 10.1097/EDE.0b013e318163152a.

PMID:
18223485
13.

Secondary sex ratio among women exposed to diethylstilbestrol in utero.

Wise LA, Palmer JR, Hatch EE, Troisi R, Titus-Ernstoff L, Herbst AL, Kaufman R, Noller KL, Hoover RN.

Environ Health Perspect. 2007 Sep;115(9):1314-9.

14.

Preeclampsia risk in women exposed in utero to diethylstilbestrol.

Troisi R, Titus-Ernstoff L, Hyer M, Hatch EE, Robboy SJ, Strohsnitter W, Palmer JR, Øglaend B, Adam E, Kaufman R, Herbst AL, Hoover RN.

Obstet Gynecol. 2007 Jul;110(1):113-20.

PMID:
17601905
15.

Cancer risk in women prenatally exposed to diethylstilbestrol.

Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, Strohsnitter WC, Kaufman R, Herbst AL, Hoover RN.

Int J Cancer. 2007 Jul 15;121(2):356-60.

16.

Prenatal diethylstilbestrol exposure and risk of breast cancer.

Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1509-14.

17.

Age at natural menopause in women exposed to diethylstilbestrol in utero.

Hatch EE, Troisi R, Wise LA, Hyer M, Palmer JR, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Adam E, Noller KL, Herbst AL, Robboy S, Hartge P, Hoover RN.

Am J Epidemiol. 2006 Oct 1;164(7):682-8. Epub 2006 Aug 3.

PMID:
16887893
18.

Mortality in women given diethylstilbestrol during pregnancy.

Titus-Ernstoff L, Troisi R, Hatch EE, Palmer JR, Wise LA, Ricker W, Hyer M, Kaufman R, Noller K, Strohsnitter W, Herbst AL, Hartge P, Hoover RN.

Br J Cancer. 2006 Jul 3;95(1):107-11. Epub 2006 Jun 20.

19.

Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).

Titus-Ernstoff L, Troisi R, Hatch EE, Wise LA, Palmer J, Hyer M, Kaufman R, Adam E, Strohsnitter W, Noller K, Herbst AL, Gibson-Chambers J, Hartge P, Hoover RN.

Int J Epidemiol. 2006 Aug;35(4):862-8. Epub 2006 May 24.

PMID:
16723367
20.

Hypospadias in sons of women exposed to diethylstilbestrol in utero.

Palmer JR, Wise LA, Robboy SJ, Titus-Ernstoff L, Noller KL, Herbst AL, Troisi R, Hoover RN.

Epidemiology. 2005 Jul;16(4):583-6.

PMID:
15951681
21.

Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure.

Wise LA, Palmer JR, Rowlings K, Kaufman RH, Herbst AL, Noller KL, Titus-Ernstoff L, Troisi R, Hatch EE, Robboy SJ.

Obstet Gynecol. 2005 Jan;105(1):167-73.

PMID:
15625159
22.

Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).

Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, Colton T, Hoover RN.

Cancer Causes Control. 2002 Oct;13(8):753-8.

PMID:
12420954
23.

Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).

Hatch EE, Herbst AL, Hoover RN, Noller KL, Adam E, Kaufman RH, Palmer JR, Titus-Ernstoff L, Hyer M, Hartge P, Robboy SJ.

Cancer Causes Control. 2001 Nov;12(9):837-45.

PMID:
11714112
24.

The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note.

Herbst AL, Pickett KE, Follen M, Noller KL.

Obstet Gynecol. 2001 Nov;98(5 Pt 1):849-51.

PMID:
11704181
25.

Infertility among women exposed prenatally to diethylstilbestrol.

Palmer JR, Hatch EE, Rao RS, Kaufman RH, Herbst AL, Noller KL, Titus-Ernstoff L, Hoover RN.

Am J Epidemiol. 2001 Aug 15;154(4):316-21.

PMID:
11495854
26.

Cancer risk in men exposed in utero to diethylstilbestrol.

Strohsnitter WC, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L, Kaufman RH, Adam E, Herbst AL, Hatch EE.

J Natl Cancer Inst. 2001 Apr 4;93(7):545-51.

PMID:
11287449
27.
28.

Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy.

Titus-Ernstoff L, Hatch EE, Hoover RN, Palmer J, Greenberg ER, Ricker W, Kaufman R, Noller K, Herbst AL, Colton T, Hartge P.

Br J Cancer. 2001 Jan 5;84(1):126-33.

29.

Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.

Kaufman RH, Adam E, Hatch EE, Noller K, Herbst AL, Palmer JR, Hoover RN.

Obstet Gynecol. 2000 Oct;96(4):483-9.

PMID:
11004345
30.

Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma.

Palmer JR, Anderson D, Helmrich SP, Herbst AL.

Obstet Gynecol. 2000 Jun;95(6 Pt 1):814-20.

PMID:
10831973
31.
32.

Diethylstilbestrol and adenocarcinoma of the vagina.

Herbst AL.

Am J Obstet Gynecol. 1999 Dec;181(6):1576-8; discussion 1579. No abstract available.

PMID:
10601947
33.

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971.

Herbst AL, Ulfelder H, Poskanzer DC, Longo LD.

Am J Obstet Gynecol. 1999 Dec;181(6):1574-5. No abstract available.

PMID:
10601946
34.

Adjusting to the present: presidential address.

Herbst AL.

Am J Obstet Gynecol. 1999 Apr;180(4):779-83. No abstract available.

PMID:
10203644
35.

Advanced Technologies in Cervical Cancer Screening ASCCP Biennial Meeting 1998.

Cox JT, Herbst AL, Kinney W, Lorincz AT, Richart RM, Schiffman MH.

J Low Genit Tract Dis. 1999 Jan;3(1 Suppl):S8. No abstract available.

PMID:
25950436
36.
37.

Age at menarche among diethylstilbestrol granddaughters.

Wilcox AJ, Umbach DM, Hornsby PP, Herbst AL.

Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):835-6.

PMID:
7573253
38.

Fertility in men exposed prenatally to diethylstilbestrol.

Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL.

N Engl J Med. 1995 May 25;332(21):1411-6.

39.

Onset of menopause in women exposed to diethylstilbestrol in utero.

Hornsby PP, Wilcox AJ, Herbst AL.

Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):92-5.

PMID:
7847565
40.

Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.

Waggoner SE, Mittendorf R, Biney N, Anderson D, Herbst AL.

Gynecol Oncol. 1994 Nov;55(2):238-44.

PMID:
7959291
41.

DES exposure: an update.

Mittendorf R, Herbst AL.

Contemp Pediatr. 1994 Nov;11(11):59-62, 64, 66 passim. Review.

PMID:
10150281
42.

Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.

Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL.

Obstet Gynecol. 1994 Sep;84(3):404-8.

PMID:
8058239
43.

OCs and genital tract malignancies.

Herbst AL.

Dialogues Contracept. 1994 Summer;4(3):5-7.

PMID:
12345575
44.

Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH.

JAMA. 1994 Jun 15;271(23):1866-9. No abstract available.

PMID:
8196145
45.

The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease.

Herbst AL.

Am J Obstet Gynecol. 1994 Apr;170(4):1099-105; discussion 1105-7. Review.

PMID:
8166193
46.

Effects on the menstrual cycle of in utero exposure to diethylstilbestrol.

Hornsby PP, Wilcox AJ, Weinberg CR, Herbst AL.

Am J Obstet Gynecol. 1994 Mar;170(3):709-15.

PMID:
8141188
47.

Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis.

Mittendorf R, Aronson MP, Berry RE, Williams MA, Kupelnick B, Klickstein A, Herbst AL, Chalmers TC.

Am J Obstet Gynecol. 1993 Nov;169(5):1119-24.

PMID:
8238170
48.

Impact of contraception on gynecologic cancers.

Herbst AL, Berek JS.

Am J Obstet Gynecol. 1993 Jun;168(6 Pt 2):1980-5. Review.

PMID:
8512041
49.

Prenatal diethylstilbestrol exposure and performance on college entrance examinations.

Wilcox AJ, Maxey J, Herbst AL.

Horm Behav. 1992 Sep;26(3):433-9.

PMID:
1398561
50.

The Bethesda system for cervical/vaginal cytologic diagnoses.

Herbst AL.

Clin Obstet Gynecol. 1992 Mar;35(1):22-7. No abstract available.

PMID:
1544245

Supplemental Content

Loading ...
Support Center